EP
CDNA icon

Elkfork Partners’s CareDx CDNA Stock Holding History

Elkfork Partners’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$18K Buy
+816
New +$22.6K ﹤0.01% 1036

Other funds holding CDNA

FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Elkfork Partners's CDNA Position: Q3 2019 in Review

Elkfork Partners opened a new position in CareDx (CDNA) in Q3 2019: 816 shares worth $18K. The stake represents ﹤0.01% of the portfolio and ranks #1036 among its holdings.

174 funds tracked by Wall St. Rank hold CDNA as of Q3 2019.

  • Elkfork Partners held 816 shares of CareDx worth $18K as of Q3 2019.
  • CareDx was a new Elkfork Partners position in Q3 2019.
  • CareDx made up ﹤0.01% of Elkfork Partners's portfolio in Q3 2019, its #1036 holding.
  • 174 funds tracked by Wall St. Rank held CareDx as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.